naadp has been researched along with brefeldin a in 1 studies
| Studies (naadp) | Trials (naadp) | Recent Studies (post-2010) (naadp) | Studies (brefeldin a) | Trials (brefeldin a) | Recent Studies (post-2010) (brefeldin a) |
|---|---|---|---|---|---|
| 411 | 0 | 184 | 2,600 | 1 | 456 |
| Protein | Taxonomy | naadp (IC50) | brefeldin a (IC50) |
|---|---|---|---|
| major prion protein preproprotein Prp precursor | Homo sapiens (human) | 3.505 | |
| nuclear receptor subfamily 0 group B member 1 | Homo sapiens (human) | 0.1343 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brailoiu, E; Brailoiu, GC; Deliu, E; Motoc, D; Tica, AA | 1 |
1 other study(ies) available for naadp and brefeldin a
| Article | Year |
|---|---|
Intracellular angiotensin II activates rat myometrium.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Arsenicals; Autophagy; Brefeldin A; Calcium Signaling; Carbolines; Cells, Cultured; Egtazic Acid; Endocytosis; Endoplasmic Reticulum; Endosomes; Enzyme Inhibitors; Estrenes; Female; Heparin; Imidazoles; Inositol 1,4,5-Trisphosphate Receptors; Losartan; Lysosomes; Macrocyclic Compounds; Macrolides; Models, Biological; Myometrium; NADP; Oxazoles; Piperazines; Pyridines; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Ryanodine; Saralasin; Signal Transduction; Sirolimus; Type C Phospholipases; Uterus | 2011 |